Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study)

American Journal of Cardiology

Volumn 85, Issue 12, 2000, Pages 1395-1400

  Haffner, Steven M ^a   Agostino Jr , Ralph D' ^b   Saad, Mohammed F ^c   O'Leary, Daniel H ^d   Savage, Peter J ^e   Rewers, Marian ^f   Selby, Joe ^g   Bergman, Richard N ^h   Mykkänen, Leena ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^g DIVISION OF RESEARCH   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; ETHNIC GROUP; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ARTERIOSCLEROSIS; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CAROTID ARTERY, INTERNAL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA;

EID: 0034660591     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00784-0     Document Type: Article

References (29)

1. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Coronary heart disease mortality in type 2 diabetic and non-diabetic subjects with and without previous myocardial infarction. N Engl J Med. 339:1998;229-234.
2. World Health Organization. Diabetes Mellitus Report of a WHO Study Group. Technical Report Series No. 727. Geneva,1985.
3. Report of the Expert Committee on Diabetes Mellitus. Diabetes Care. 20:1997;1183-1197.
4. Kuller L.H., Shemanski L., Psaty B.M., Borhani N.O., Gardin J., Haan M.N., O'Leary D.H., Savage P.J., Tell G.S., Tracy R. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation. 92:1995;720-726.
5. Heiss G., Sharrett A.R., Barnes R., Chambless L.E., Szklo M., Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations association with cardiovascular risk factors in the ARIC study . Am J Epidemiol. 134:1991;250-256.
6. O'Leary D.H., Polak J.F., Wolfson S.K., Bond M.G., Bommer W., Sheth S., Psaty B.M., Sharrett A.R., Manolio T.A. Use of sonography to evaluate carotid atherosclerosis in the elderly the Cardiovascular Health Study . Stroke. 22:1991;1155-1163.
7. Burke G.L., Evans G.W., Riley W.A., Sharrett A.R., Howard G., Barnes R.W., Rosamond W., Crow R.S., Rautaharju P.M., Heiss G. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults the Atherosclerosis Risk in Communities (ARIC) Study . Stroke. 26:1995;386-391.
8. Folsom A.R., Eckfeldt J.H., Weitzman S., Ma J., Chambless L.E., Barnes R.W., Cram K.B., Hutchinson R.G. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke. 25:1994;66-73.
9. Wagenknecht L.E., Mayer E.J., Rewers M., Haffner S.M., Selby J., Burke G.M., Henkin L., Howard G., Savage P.J., Saad M.F., Bergman R.N., Hamman R. The Insulin Resistance Atherosclerosis Study (IRAS). Objectives, design and recruitment results. Ann Epidemiol. 5:1995;464-471.
10. D'Agostino R. Jr, Burke G., O'Leary D., Rewers M., Selby J., Savage P.J., Saad M.F., Bergman R.N., Howard G., Haffner S.M. Ethnic differences in carotid wall thickness in normoglycemic African Americans, Hispanics and non-Hispanic whites the Insulin Resistance Atherosclerosis Study (IRAS) . Stroke. 27:1996;1744-1749.
11. Haffner S.M., D'Agostino R. Jr, Saad M.F., Rewers M., Mykkänen L., Selby J., Howard G., Savage P.J., Hamman R.F., Wagenkneckt L., Bergman R.N. Increased insulin resistance and insulin secretion in non-diabetic African Americans and Hispanics compared to non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes. 45:1996;742-748.
12. Bergman R.N., Finegood D.T., Ader M. Assessment of insulin sensitivity in vivo. Endocrine Rev. 6:1985;45-86.
13. Pacini G., Bergman R.N. MINMOD. A computer program to calculate insulin sensitivity and pancreatic responsibility from the frequently sampled intravenous glucose tolerance test. Comput Meth Progr Biomed. 23:1986;113-122.
14. Krauss R.M., Burke D.J. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 23:1982;97-104.
15. Haffner S.M., Mykkänen L., Stern M.P., Paidi M., Howard B.V. Greater effect of diabetes on LDL size in women than in men. Diabetes Care. 17:1994;1164-1171.
16. Geffken D., Keating F., Kennedy M., Cornell E., Bovill E., Tracy R. The measurement of fibrinogen in population-based research studies on instrumentation and methodology . Arch Pathol Lab Med. 118:1994;1106-1109.
17. Clauss A. Gerinnungs-physiologische schnell-methode zur bestimmung des fibrinogen. Acta Haematol. 17:1957;237-246.
18. Macy E., Meilahn E., Declerck P., Tracy R. Sample preparation for plasma measurement of plasminogen activator inhibitor-1 antigen in large population studies. Arch Path Lab Med. 117:1993;67-70.
19. Wong M., Edelstein J., Wollman J., Bond M.G. Ultrasonic-pathological comparison of the human arterial wall. Verification of intima-media thickness. Arterio Thromb. 13:1993;482-486.
20. Gillum R.F., Fortmann S.P., Prineas R.J., Kottke T.E. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J. 108:1984;150-158.
21. The Atherosclerosis Risk in Communities (ARIC) Study design ad objectives . Am J Epidemiol. 129:1989;687-702.
22. Prineas R.J., Crow R.S., Blackburn H. The Minnesota Code Manual of Electrographic Findings . 1982;John Wright-PGS, Boston.
23. Abbott R.D., Donahue R.P., Kannel W.B., Wilson P.W. The impact of diabetes on survival following MI in men vs. women. The Framingham Study. JAMA. 260:1988;3456-3460.
24. Miettinen H., Lehto S., Salomaa V.V., Mähönen M., Niemalä M., Haffner S.M., Pyörälä K., Tuomilehto J. Impact of diabetes on mortality after first myocardial infarction. Diabetes Care. 21:1998;69-75.
25. Pyörälä K., Pedersen T.R., Kjeksus J., Faergerman O., Olsson A.G., Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease a subgroup analyses of the Scandinavian Simvastatin Survival Study (4S) . Diabetes Care. 20:1997;614-660.
26. Goldberg R.B., Mellies M.J., Sacks F.M., Moyé L.A., Howard B.V., Howard W.J., Davis B.R., Cole T.G., Pferrer M.A., Braunwald E. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-tolerant myocardial infarction survivors with average cholesterol levels. Circulation. 98:1998;2513-2519.
27. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., Gotto A.M. Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels results of AFCAPS/TexCAPS . JAMA. 279:1998;1615-1622.
28. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol (Adult Treatment Panel II). Expert Panel on detection, evaluation and treatment of high load cholesterol. JAMA. 209:1993;3015-3023.
29. Johannesson M., Jönsson B., Kjekshus J., Olsson A.G., Pedersen T.R., Wedel H. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. N Engl J Med. 336:1997;332-336.